Michael S. Balzer @ms_balzer

Tweets

269
Followers

479
Following

475
Likes

336

Michael S. Balzer @ms_balzer

2 years ago

Alright, #MedTwitter #NephTwitter 🫘 The time has come to move on... Would love to stay in touch! Find me at 🦋 bsky.app/profile/ms-bal…

2 0 4 413 0

View Details

NEJM @NEJM

2 years ago

Original Article: Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease (EMPA-KIDNEY) nej.md/3NE3W7K #KidneyWk | @ASNKidney

0 73 209 39K 47

View Details

Michael S. Balzer @ms_balzer

2 years ago

Amazing new spatial data in DKD (1.7M cells) from @BernhardDumoul1 @KSusztak lab #kidneyweek2024

1 3 27 2K 3

View Details

Michael S. Balzer @ms_balzer

2 years ago

Instrumental work by Hiroaki Kikuchi from @MarkKnepper6 lab on what instigates renal compensatory growth #kidneyweek2024

0 0 4 341 2

View Details

Michael S. Balzer @ms_balzer

2 years ago

Fantastic talk by @MiguelCheSoares on labile heme and Host-Microbe interactions in the context of AKI #KidneyWk2024

1 1 3 285 0

View Details

Michael S. Balzer @ms_balzer

2 years ago

Want to know how to extend your kidneys’ lifespan? Starting off “Opposing Demands in Kidney Injury: How to Adapt” with Martin Späth leveraging caloric restriction for kidney injury. #kidneyweek2024

0 0 2 326 0

View Details

Michael S. Balzer @ms_balzer

2 years ago

Fatty acid oxidation in AKI is 🔥🔥🔥No seats left @SunderSimsLucas

0 0 3 251 0

View Details

Michael S. Balzer @ms_balzer

2 years ago

Is fibrosis🐓or🥚? Fantastic talk in the spatial session by @Ina_M_Schiessl on intravital tracking of kidney tubules. #kidneyweek2024 #kidneyweek

1 2 27 1K 4

View Details

ninagoerlich @ninagoerlich

2 years ago

Let’s go #kidneyweek2024 @ASNKidney @lfwgnr @P_Enghard @ms_balzer @Alibrandi_SA

0 1 13 649 0

View Details

Michael S. Balzer @ms_balzer

2 years ago

Congrats @AminAbedini1990 @KSusztak and team! 🔥🔥🔥

🔥😀Super-super excited to report the publication of "Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression" in @NatureGenet rdcu.be/dONoW by @AminAbedini1990 and Jon Levinsohn #kidney

14 47 180 16K 24

0 0 6 337 0

View Details

UKE Hamburg @UKEHamburg

2 years ago

Prof. Dr. Tobias Huber aus dem #UKEHamburg ist vom @ERC_Research mit ERC Advanced Grant ausgezeichnet worden. Sein Forschungsprojekt zu einer Form der Nierenfilterschädigung (fokal segmentalen Glomerulosklerose, FSGS) wird mit 2,5 Mio. Euro gefördert: t1p.de/m49gz

4 6 45 5K 0

View Details

Michael S. Balzer @ms_balzer

2 years ago

@UKEHamburg @Tobias_B_Huber @ERC_Research Congrats!

0 0 1 105 0

View Details

JASN_News @JASN_News

2 years ago

"The nephrology community has lost one of its truly remarkable figures..." Drs @JochenReiser and Martin Zeier remember the life and legacy of Eberhard Ritz bit.ly/JASN0304

1 2 10 2K 0

View Details

Leonardo V. Riella @LVRiella

2 years ago

With tremendous joy, I share that our patient who received a gene-edited pig kidney transplant was discharged home today after removal of his dialysis access. We hope that this is a first step that will bring hope to many patients waiting for a kidney transplant #xenotransplant

121 453 2K 227K 81

View Details

evo-devo @Xiaojie_Qiu

2 years ago

Thrilled to share that Dynamo v1.4 (github.com/aristoteleo/dy…) for single cell and metabolic labeling enabled RNA velocity vector field learning and prediction is now on PyPi! This is one of our biggest upgrades of Dynamo since early 2023. In this new release, we made the following extensive changes: 1) Implemented an interactive Shiny web application for in silico perturbation and least square action path analyses, see: dynamo-release.readthedocs.io/en/latest/Shin… 2). More 3D plots with Plotly and Pyvista: 3D scatters with Plotly and Pyvista: - dyn.pl.scatters_interactive(). 3D vectors with Plotly and Pyvista: -dyn.pl.cell_wise_vectors_3d(). 3D topography with Plotly and Pyvista: - dyn.pl.topography_3d(). 3D animation with Pyvista: dyn.mv.PyvistaAnim(). 3). Extensive reorganization of the code in tools module: dynamo-release.readthedocs.io/en/latest/API.… 4). Various tutorial updates and bug fixes are made. See our detailed release log here: dynamo-release.readthedocs.io/en/latest/Rele… In our next release, we are aiming to integrate Storm (biorxiv.org/content/10.110…) and a few other new methods in our next releases. Stay tuned!

4 39 175 21K 51

View Details

Michael S. Balzer @ms_balzer

2 years ago

@Hongbo919Liu @KSusztak Congrats, Hongbo! Way to go!

1 0 2 93 0

View Details

Christoph Kuppe @KuppeChristoph

2 years ago

🎉 Happy to share our first 📜 2024!🔬 Our review article in @GenomeMedicine on the innovative use of spatial multi-omics. Discover how these technologies are unlocking new understandings of cardiovascular disease. 🚀rdcu.be/dwnVi @UniklinikAachen @SpringerNature @RWTH

1 18 77 9K 7

View Details

Michael S. Balzer @ms_balzer

2 years ago

Huge thank you 🙏to all involved: 👏@cetin_sz, Kathrien Abdank, @AminAbedini1990 @KSusztak Kai-Uwe Eckardt @BIH_Innovation @EKFStiftung Check out the 🔥paper in @NDTsocial: doi.org/10.1093/ndt/gf… Eo/🧵

0 6 27 3K 4

View Details

Michael S. Balzer @ms_balzer

2 years ago

CONCLUSION: our straightforward analytical framework ✅effectively positioned pre-clinical models along human biology (AKI-to-CKD); ✅showcased robust biological pathway concordance across species; ✅identified problematic datasets and samples. 6/🧵

1 0 9 461 0

View Details

Michael S. Balzer @ms_balzer

2 years ago

❓❓❓Ever wondered how well pre-clinical #kidneydisease models translate to the human? Recent #singlecell work led by top students in my lab, Kathrien Abdank & @cetin_sz, provides answers. 1/🧵